281 related articles for article (PubMed ID: 28215181)
1. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
[TBL] [Abstract][Full Text] [Related]
2. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
[TBL] [Abstract][Full Text] [Related]
3. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
[TBL] [Abstract][Full Text] [Related]
4. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
[TBL] [Abstract][Full Text] [Related]
5. Myocardial fibrosis evaluated by diffusion-weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy.
Wu R; An DA; Shi RY; Chen BH; Jiang M; Bacyinski A; Han TT; Hu J; Xu JR; Wu LM
J Magn Reson Imaging; 2018 Oct; 48(4):1139-1146. PubMed ID: 29601139
[TBL] [Abstract][Full Text] [Related]
6. T
Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
[TBL] [Abstract][Full Text] [Related]
7. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1.
Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB
JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587
[TBL] [Abstract][Full Text] [Related]
9. Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
Thompson EW; Kamesh Iyer S; Solomon MP; Li Z; Zhang Q; Piechnik S; Werys K; Swago S; Moon BF; Rodgers ZB; Hall A; Kumar R; Reza N; Kim J; Jamil A; Desjardins B; Litt H; Owens A; Witschey WRT; Han Y
J Cardiovasc Magn Reson; 2021 Oct; 23(1):120. PubMed ID: 34689798
[TBL] [Abstract][Full Text] [Related]
10. T1 mapping in children and young adults with hypertrophic cardiomyopathy.
Parekh K; Markl M; Deng J; de Freitas RA; Rigsby CK
Int J Cardiovasc Imaging; 2017 Jan; 33(1):109-117. PubMed ID: 27659477
[TBL] [Abstract][Full Text] [Related]
11. 3-Dimensional regional and global strain abnormalities in hypertrophic cardiomyopathy.
Satriano A; Heydari B; Guron N; Fenwick K; Cheung M; Mikami Y; Merchant N; Lydell CP; Howarth AG; Fine NM; White JA
Int J Cardiovasc Imaging; 2019 Oct; 35(10):1913-1924. PubMed ID: 31144257
[TBL] [Abstract][Full Text] [Related]
12. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
[TBL] [Abstract][Full Text] [Related]
14. Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.
Mathur S; Dreisbach JG; Karur GR; Iwanochko RM; Morel CF; Wasim S; Nguyen ET; Wintersperger BJ; Hanneman K
J Cardiovasc Magn Reson; 2019 Aug; 21(1):45. PubMed ID: 31366357
[TBL] [Abstract][Full Text] [Related]
15. Kinetic index combining native and postcontrast myocardial T1 in hypertrophic cardiomyopathy.
Kachenoura N; Besson-Hajji L; Graves MJ; Reid S; Soulat G; Ashrafpoor G; De Cesare A; Hagege A; Redheuil A; Mousseaux E
J Magn Reson Imaging; 2015 Dec; 42(6):1713-22. PubMed ID: 25980519
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic cardiomyopathy and left ventricular hypertrophy in hypertensive heart disease with mildly reduced or preserved ejection fraction: insight from altered mechanics and native T1 mapping.
Wu LM; An DL; Yao QY; Ou YZ; Lu Q; Jiang M; Xu JR
Clin Radiol; 2017 Oct; 72(10):835-843. PubMed ID: 28552325
[TBL] [Abstract][Full Text] [Related]
17. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
[TBL] [Abstract][Full Text] [Related]
18. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
[TBL] [Abstract][Full Text] [Related]
20. Evaluation the relationship between myocardial fibrosis and left ventricular torsion measured by cardiac magnetic resonance feature-tracking in hypertrophic cardiomyopathy patients with preserved ejection fraction.
Zhong Y; Li C; Yu Y; Du Y; Bai Y; Wang X; Dai X; Fan G; Wang G
Int J Cardiovasc Imaging; 2024 Apr; 40(4):921-930. PubMed ID: 38448705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
